Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinoma von Atkins, Michael B., Tannir, Nizar M.

Volltext

Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma von Choueiri, Toni K, Escudier, Bernard, Powles, Thomas, Mainwaring, Paul N, Rini, Brian I, Donskov, Frede, Hammers, Hans, Hutson, Thomas E, Lee, Jae-Lyun, Peltola, Katriina, Roth, Bruce J, Bjarnason, Georg A, Géczi, Lajos, Keam, Bhumsuk, Maroto, Pablo, Heng, Daniel Y.C, Schmidinger, Manuela, Kantoff, Philip W, Borgman-Hagey, Anne, Hessel, Colin, Scheffold, Christian, Schwab, Gisela M, Tannir, Nizar M, Motzer, Robert J

Volltext

Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial von Choueiri, Toni K, Dr, Escudier, Bernard, MD, Powles, Thomas, Prof, Tannir, Nizar M, Prof, Mainwaring, Paul N, MD, Rini, Brian I, Prof, Hammers, Hans J, MD, Donskov, Frede, MD, Roth, Bruce J, Prof, Peltola, Katriina, MD, Lee, Jae Lyun, Prof, Heng, Daniel Y C, MD, Schmidinger, Manuela, Prof, Agarwal, Neeraj, MD, Sternberg, Cora N, Prof, McDermott, David F, MD, Aftab, Dana T, PhD, Hessel, Colin, MS, Scheffold, Christian, MD, Schwab, Gisela, MD, Hutson, Thomas E, Prof, Pal, Sumanta, MD, Motzer, Robert J, Prof

Volltext

A Model Linking Sickle Cell Hemoglobinopathies and SMARCB1 Loss in Renal Medullary Carcinoma von Msaouel, Pavlos, Tannir, Nizar M, Walker, Cheryl Lyn

Volltext

Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non–Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial von Tannir, Nizar M, Jonasch, Eric, Albiges, Laurence, Altinmakas, Emre, Ng, Chaan S, Matin, Surena F, Wang, Xuemei, Qiao, Wei, Dubauskas Lim, Zita, Tamboli, Pheroze, Rao, Priya, Sircar, Kanishka, Karam, Jose A, McDermott, David F, Wood, Christopher G, Choueiri, Toni K

Volltext

PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma von Liu, Xian-De, Kong, Wen, Peterson, Christine B., McGrail, Daniel J., Hoang, Anh, Zhang, Xuesong, Lam, Truong, Pilie, Patrick G., Zhu, Haifeng, Beckermann, Kathryn E., Haake, Scott M., Isgandrova, Sevinj, Martinez-Moczygemba, Margarita, Sahni, Nidhi, Tannir, Nizar M., Lin, Shiaw-Yih, Rathmell, W. Kimryn, Jonasch, Eric

Volltext

Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial von Albiges, Laurence, Tannir, Nizar M, Burotto, Mauricio, McDermott, David, Plimack, Elizabeth R, Barthélémy, Philippe, Porta, Camillo, Powles, Thomas, Donskov, Frede, George, Saby, Kollmannsberger, Christian K, Gurney, Howard, Grimm, Marc-Oliver, Tomita, Yoshihiko, Castellano, Daniel, Rini, Brian I, Choueiri, Toni K, Saggi, Shruti Shally, McHenry, M Brent, Motzer, Robert J

Volltext

Efficacy of Nivolumab plus Ipilimumab According to Number of IMDC Risk Factors in CheckMate 214 von Escudier, Bernard, Motzer, Robert J., Tannir, Nizar M., Porta, Camillo, Tomita, Yoshihiko, Maurer, Matthew A., McHenry, M. Brent, Rini, Brian I.

Volltext

Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer von APARICIO, Ana M, HARZSTARK, Andrea L, TANNIR, Nizar M, ZURITA, Amado J, MATHEW, Paul, ARAP, Wadih, TRONCOSO, Patricia, THALL, Peter F, LOGOTHETIS, Christopher J, CORN, Paul G, SIJIN WEN, ARAUJO, John C, TU, Shi-Ming, PAGLIARO, Lance C, KIM, Jeri, MILLIKAN, Randall E, RYAN, Charles

Volltext

Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma von Msaouel, Pavlos, Malouf, Gabriel G., Su, Xiaoping, Yao, Hui, Tripathi, Durga N., Soeung, Melinda, Gao, Jianjun, Rao, Priya, Coarfa, Cristian, Creighton, Chad J., Bertocchio, Jean-Philippe, Kunnimalaiyaan, Selvi, Multani, Asha S., Blando, Jorge, He, Rong, Shapiro, Daniel D., Perelli, Luigi, Srinivasan, Sanjana, Carbone, Federica, Pilié, Patrick G., Karki, Menuka, Seervai, Riyad N.H., Vokshi, Bujamin H., Lopez-Terrada, Dolores, Cheng, Emily H., Tang, Ximing, Lu, Wei, Wistuba, Ignacio I., Thompson, Timothy C., Davidson, Irwin, Giuliani, Virginia, Schlacher, Katharina, Carugo, Alessandro, Heffernan, Timothy P., Sharma, Padmanee, Karam, Jose A., Wood, Christopher G., Walker, Cheryl L., Genovese, Giannicola, Tannir, Nizar M.

Volltext

Outcomes for Spine Stereotactic Body Radiation Therapy and an Analysis of Predictors of Local Recurrence von Bishop, Andrew J., MD, Tao, Randa, MD, Rebueno, Neal C., CMS, Christensen, Eva N., MD, PhD, Allen, Pamela K., PhD, Wang, Xin A., PhD, Amini, Behrang, MD, PhD, Tannir, Nizar M., MD, Tatsui, Claudio E., MD, Rhines, Laurence D., MD, Li, Jing, MD, PhD, Chang, Eric L., MD, Brown, Paul D., MD, Ghia, Amol J., MD

Volltext

Reduction of Cancer-Related Fatigue With Dexamethasone: A Double-Blind, Randomized, Placebo-Controlled Trial in Patients With Advanced Cancer von YENNURAJALINGAM, Sriram, FRISBEE-HUME, Susan, DALAL, Shalini, MASSIE, Lisa, REDDY, Suresh K, BRUERA, Eduardo, LYNN PALMER, J, DELGADO-GUAY, Marvin O, BULL, Janet, PHAN, Alexandria T, TANNIR, Nizar M, KEATING LITTON, Jennifer, REDDY, Akhila, HUI, David

Volltext

Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a random... von Motzer, Robert J, Escudier, Bernard, McDermott, David F, Arén Frontera, Osvaldo, Melichar, Bohuslav, Powles, Thomas, Donskov, Frede, Plimack, Elizabeth R, Barthélémy, Philippe, Hammers, Hans J, George, Saby, Grünwald, Viktor, Porta, Camillo, Neiman, Victoria, Ravaud, Alain, Choueiri, Toni K, Rini, Brian I, Salman, Pamela, Kollmannsberger, Christian K, Tykodi, Scott S, Grimm, Marc-Oliver, Gurney, Howard, Leibowitz-Amit, Raya, Geertsen, Poul F, Amin, Asim, Tomita, Yoshihiko, McHenry, M Brent, Saggi, Shruti Shally, Tannir, Nizar M

Volltext

Landscape of DNA Virus Associations across Human Malignant Cancers: Analysis of 3,775 Cases Using RNA-Seq von Khoury, Joseph D, Tannir, Nizar M, Williams, Michelle D, Chen, Yunxin, Yao, Hui, Zhang, Jianping, Thompson, Erika J, Meric-Bernstam, Funda, Medeiros, L Jeffrey, Weinstein, John N, Su, Xiaoping

Volltext

Cabozantinib: an Active Novel Multikinase Inhibitor in Renal Cell Carcinoma von Tannir, Nizar M., Schwab, Gisela, Grünwald, Viktor

Volltext

Optimizing patient selection for cytoreductive nephrectomy based on outcomes in the contemporary era of systemic therapy von McIntosh, Andrew G., Umbreit, Eric C., Holland, Levi C., Gu, Cindy, Tannir, Nizar M., Matin, Surena F., Karam, Jose A., Culp, Stephen H., Wood, Christopher G.

Volltext

Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy von Kim, Sang T., Chu, Yanshuo, Misoi, Mercy, Suarez-Almazor, Maria E., Tayar, Jean H., Lu, Huifang, Buni, Maryam, Kramer, Jordan, Rodriguez, Emma, Hussain, Zulekha, Neelapu, Sattva S., Wang, Jennifer, Shah, Amishi Y., Tannir, Nizar M., Campbell, Matthew T., Gibbons, Don L., Cascone, Tina, Lu, Charles, Blumenschein, George R., Altan, Mehmet, Lim, Bora, Valero, Vincente, Loghin, Monica E., Tu, Janet, Westin, Shannon N., Naing, Aung, Garcia-Manero, Guillermo, Abdel-Wahab, Noha, Tawbi, Hussein A., Hwu, Patrick, Oliva, Isabella C. Glitza, Davies, Michael A., Patel, Sapna P., Zou, Jun, Futreal, Andrew, Diab, Adi, Wang, Linghua, Nurieva, Roza

Volltext

Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinoma von Campbell, Matthew T., Matin, Surena F., Tam, Alda L., Sheth, Rahul A., Ahrar, Kamran, Tidwell, Rebecca S., Rao, Priya, Karam, Jose A., Wood, Christopher G., Tannir, Nizar M., Jonasch, Eric, Gao, Jianjun, Zurita, Amado J., Shah, Amishi Y., Jindal, Sonali, Duan, Fei, Basu, Sreyashi, Chen, Hong, Espejo, Alexsandra B., Allison, James P., Yadav, Shalini S., Sharma, Padmanee

Volltext

SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistance von Vokshi, Bujamin H., Davidson, Guillaume, Tawanaie Pour Sedehi, Nassim, Helleux, Alexandra, Rippinger, Marc, Haller, Alexandre R., Gantzer, Justine, Thouvenin, Jonathan, Baltzinger, Philippe, Bouarich, Rachida, Manriquez, Valeria, Zaidi, Sakina, Rao, Priya, Msaouel, Pavlos, Su, Xiaoping, Lang, Hervé, Tricard, Thibault, Lindner, Véronique, Surdez, Didier, Kurtz, Jean-Emmanuel, Bourdeaut, Franck, Tannir, Nizar M., Davidson, Irwin, Malouf, Gabriel G.

Volltext

p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors von Carugo, Alessandro, Minelli, Rosalba, Sapio, Luigi, Soeung, Melinda, Carbone, Federica, Robinson, Frederick S., Tepper, James, Chen, Ziheng, Lovisa, Sara, Svelto, Maria, Amin, Samirkumar, Srinivasan, Sanjana, Del Poggetto, Edoardo, Loponte, Sara, Puca, Francesca, Dey, Prasenjit, Malouf, Gabriel G., Su, Xiaoping, Li, Liren, Lopez-Terrada, Dolores, Rakheja, Dinesh, Lazar, Alexander J., Netto, George J., Rao, Priya, Sgambato, Alessandro, Maitra, Anirban, Tripathi, Durga N., Walker, Cheryl L., Karam, Jose A., Heffernan, Timothy P., Viale, Andrea, Roberts, Charles W.M., Msaouel, Pavlos, Tannir, Nizar M., Draetta, Giulio F., Genovese, Giannicola

Volltext